LLYEli Lilly & Co.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 18090
Ticker: LLY
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 1970-07-09
Round lot: 40
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: LLY

Detail

Enriched 2026-08-14 20:47

Market cap: $1,087,705,199,278.2
Shares outstanding (class): 941,357,065
Shares outstanding (weighted): 891,357,065
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 50,000
Location: INDIANAPOLIS, IN
Homepage: https://www.lilly.com
Description: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market cap and share counts drift.

Funds holding this security

835 funds · 880 positions · $159.82B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$24.80B	1.25%	26,961,966 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$18.52B	1.30%	20,136,053 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$9.37B	1.30%	10,191,393 NS	FIGI
N/A —	—	$8.49B	1.30%	9,231,126 NS	FIGI
VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS	VUG	$8.25B	2.60%	8,971,240 NS	FIGI
Investment Co of America Investment Co of America	—	$5.57B	3.36%	6,059,533 NS	FIGI
State Street(R) Health Care Select Sector SPDR(… SELECT SECTOR SPDR TRUST	XLV	$5.30B	13.74%	5,766,540 NS	FIGI
VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS	—	$5.01B	6.92%	5,443,428 NS	FIGI
VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS	—	$4.11B	1.30%	4,467,968 NS	FIGI
American Balanced Fund American Balanced Fund	—	$3.51B	1.33%	3,811,606 NS	FIGI
iShares Russell 1000 Growth ETF iShares Trust	IWF	$2.97B	2.66%	3,230,456 NS	FIGI
Fidelity Contrafund Fidelity Contrafund	—	$2.89B	1.83%	3,145,605 NS	FIGI
New Perspective Fund New Perspective Fund	—	$2.27B	1.48%	2,464,735 NS	FIGI
JPMorgan Large Cap Growth Fund JPMorgan Trust II	—	$2.24B	2.08%	2,434,597 NS	FIGI
T. Rowe Price Blue Chip Growth Fund, Inc. T. ROWE PRICE BLUE CHIP GROWTH FUND, INC.	—	$1.73B	2.94%	1,877,119 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERLLY
FIGI_COMPOSITEBBG000BNBDC2
FIGI_SHARE_CLASSBBG001S5STL8
CIK0000059478
ISINUS5324571083
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 1
Model: deepseek
Rationale: Eli Lilly is a pharmaceutical company, classified under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.